DEGENERATION OF PYRAMIDAL PROJECTION NEURONS IN HUNTINGTONS-DISEASE CORTEX

被引:161
作者
CUDKOWICZ, M [1 ]
KOWALL, NW [1 ]
机构
[1] MASSACHUSETTS GEN HOSP,DEPT NEUROL,NEUROL SERV,EXPTL NEUROPATHOL LAB,FRUIT ST,BOSTON,MA 02114
关键词
D O I
10.1002/ana.410270217
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We examined the distribution of neuropeptide Y immunoreactive local circuit neurons and nonphosphorylated neurofilament (SMI 32) immunoreactive pyramidal projection neurons in superior frontal cortex of patients with Huntington's disease and age‐matched control subjects to determine the histological counterpart of increased neuropeptide Y and decreased glutamate concentrations previously found in the cortex of patients with Huntington's disease. We found no difference between the relative density of neuropeptide Y neurons in Huntingon's disease and control brains in regions where the relative density of SMI 32 immunoreactive neurons was significantly reduced. Animal studies show that cortical local circuit neurons are resistant to N‐methyl‐D‐aspartate‐type excitotoxins such as quinolinic acid. Relative sparing of neuropeptide Y neurons in cerebral cortex with Huntington's disease may, therefore, be a result of excessive N‐methyl‐D‐asparate receptor activation. Copyright © 1990 American Neurological Association
引用
收藏
页码:200 / 204
页数:5
相关论文
共 35 条
  • [1] SOMATOSTATIN IS INCREASED IN THE BASAL GANGLIA IN HUNTINGTON DISEASE
    ARONIN, N
    COOPER, PE
    LORENZ, LJ
    BIRD, ED
    SAGAR, SM
    LEEMAN, SE
    MARTIN, JB
    [J]. ANNALS OF NEUROLOGY, 1983, 13 (05) : 519 - 526
  • [2] REPLICATION OF THE NEUROCHEMICAL CHARACTERISTICS OF HUNTINGTONS-DISEASE BY QUINOLINIC ACID
    BEAL, MF
    KOWALL, NW
    ELLISON, DW
    MAZUREK, MF
    SWARTZ, KJ
    MARTIN, JB
    [J]. NATURE, 1986, 321 (6066) : 168 - 171
  • [3] DIFFERENTIAL SPARING OF SOMATOSTATIN-NEUROPEPTIDE-Y AND CHOLINERGIC NEURONS FOLLOWING STRIATAL EXCITOTOXIN LESIONS
    BEAL, MF
    KOWALL, NW
    SWARTZ, KJ
    FERRANTE, RJ
    MARTIN, JB
    [J]. SYNAPSE, 1989, 3 (01) : 38 - 47
  • [4] AN EXAMINATION OF NEUROPEPTIDE Y POSTMORTEM STABILITY IN AN ANIMAL-MODEL SIMULATING HUMAN AUTOPSY CONDITIONS
    BEAL, MF
    MAZUREK, MF
    LORENZ, LJ
    CHATTHA, GK
    ELLISON, DW
    MARTIN, JB
    [J]. NEUROSCIENCE LETTERS, 1986, 64 (01) : 69 - 74
  • [5] SOMATOSTATIN AND NEUROPEPTIDE-Y CONCENTRATIONS IN PATHOLOGICALLY GRADED CASES OF HUNTINGTONS-DISEASE
    BEAL, MF
    MAZUREK, MF
    ELLISON, DW
    SWARTZ, KJ
    MCGARVEY, U
    BIRD, ED
    MARTIN, JB
    [J]. ANNALS OF NEUROLOGY, 1988, 23 (06) : 562 - 569
  • [6] DIFFERENTIAL SENSITIVITY OF NEUROPEPTIDE-Y, SOMATOSTATIN AND NADPH-DIAPHORASE CONTAINING NEURONS IN RAT CORTEX AND STRIATUM TO QUINOLINIC ACID
    BOEGMAN, RJ
    PARENT, A
    [J]. BRAIN RESEARCH, 1988, 445 (02) : 358 - 362
  • [7] BRUYN GW, 1979, ADV NEUROL, V23, P83
  • [8] MONOCLONAL-ANTIBODY TO NEUROFILAMENT PROTEIN (SMI-32) LABELS A SUBPOPULATION OF PYRAMIDAL NEURONS IN THE HUMAN AND MONKEY NEOCORTEX
    CAMPBELL, MJ
    MORRISON, JH
    [J]. JOURNAL OF COMPARATIVE NEUROLOGY, 1989, 282 (02) : 191 - 205
  • [9] CONTI F, 1987, J NEUROSCI, V7, P1887
  • [10] SURVIVAL OF BASAL GANGLIA NEUROPEPTIDE Y-SOMATOSTATIN NEURONS IN HUNTINGTONS-DISEASE
    DAWBARN, D
    DEQUIDT, ME
    EMSON, PC
    [J]. BRAIN RESEARCH, 1985, 340 (02) : 251 - 260